WallStreetZenWallStreetZen

NASDAQ: SLDB
Solid Biosciences Inc Earnings & Revenue

SLDB past revenue growth

How has SLDB's revenue growth performed historically?
Company
-100%
Industry
165.61%
Market
17.84%
SLDB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SLDB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SLDB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$96.0M
Current Profit Margin
0%

SLDB Return on Equity

Current Company
-62.1%
Current Industry
-63.6%
Current Market
188%
SLDB's Return on Equity (-62.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SLDB announces earnings.

SLDB Return on Assets

Current Company
-49%
Current Industry
3%
SLDB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SLDB Return on Capital Employed

Current Company
-63.83%
Current Industry
19.6%
SLDB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLDB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SLDB$0.00-$93.43M-$96.02M-100.00%N/A
REPL$0.00-$200.44M-$209.96MN/AN/A
KALV$0.00-$107.49M-$108.30M-100.00%N/A
VYGR$250.01M$126.46M$132.33M+101.01%+128.28%
MESO$7.25MN/A-$73.06M-14.93%N/A

SLDB earnings dates

Next earnings date
May 9, 2024

Solid Biosciences Earnings & Revenue FAQ

What were SLDB's earnings last quarter?

On Invalid Date, Solid Biosciences (NASDAQ: SLDB) reported Q4 2023 earnings per share (EPS) of -$1.00, up 47.06% year over year. Total Solid Biosciences earnings for the quarter were -$20.34 million. In the same quarter last year, Solid Biosciences's earnings per share (EPS) was -$0.68.

If you're new to stock investing, here's how to buy Solid Biosciences stock.

What was SLDB's earnings growth in the past year?

As of Q1 2024, Solid Biosciences's earnings has grown year over year. Solid Biosciences's earnings in the past year totalled -$96.02 million.

What is SLDB's earnings date?

Solid Biosciences's earnings date is Invalid Date. Add SLDB to your watchlist to be reminded of SLDB's next earnings announcement.

What was SLDB's revenue last quarter?

On Invalid Date, Solid Biosciences (NASDAQ: SLDB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Solid Biosciences's revenue was $0.00.

What was SLDB's revenue growth in the past year?

As of Q1 2024, Solid Biosciences's revenue has grown -100% year over year. This is 265.61 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Solid Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.